Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome

Pharmacological Evaluation of a Novel Cannabinoid 2 (CB2) Ligand, PF-03550096, In Vitro and In Vivo by Using a Rat Model of Visceral Hypersensitivity

Akira Kikuchi, Katsuyo Ohashi, Yutaka Sugie et al. · Journal of Pharmacological Sciences · 2008 · 66 citations · Full text

5-Sulfonyl-benzimidazoles as selective CB2 agonists-Part 2

Harrie J. M. Gijsen, Michel A.J. De Cleyn, Michel Surkyn et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 30 citations · Full text

Molecular Pharmacology, Drug Target, Medicine +5

5-Sulfonyl-benzimidazoles as selective CB2 agonists

Bie Verbist, Michel A.J. De Cleyn, Michel Surkyn et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 30 citations · Full text

Molecular Pharmacology, Drug Target, Medicine +4

Optimisation of a novel series of selective CNS penetrant CB2 agonists

Christine Watson, Dafydd R. Owen, Denise Harding et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 26 citations · Full text

Cannabis Use, Combinatorial Chemistry, Novel Series +7

Colonic Mast Cell Infiltration in Rats with TNBS-Induced Visceral Hypersensitivity

Katsuyo Ohashi, Yasushi Sato, Hiroshi Iwata et al. · Journal of Veterinary Medical Science · 2007 · 25 citations · Full text

Mast Cell Disorder, Immune Regulation, Immunology +19